Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs
2
Jiangsu Kanion Pharmaceutical Co., Ltd., 58 Haichang South Road, Lianyungang 222001, China
|
Тип публикации: Journal Article
Дата публикации: 2020-09-09
scimago Q2
wos Q3
БС1
SJR: 0.610
CiteScore: 6.4
Impact factor: 3.3
ISSN: 15680266, 18734294
PubMed ID:
32901585
Drug Discovery
General Medicine
Краткое описание
Berberine, as a representative isoquinoline alkaloid, exhibits significant hypolipidemic activity in both animal models and clinical trials. Recently, a large number of studies on the lipid-lowering mechanism of berberine and studies for improving its hypolipidemic activity have been reported, but for the most part, they have been either incomplete or not comprehensive. In addition, there have been a few specific reviews on the lipid-reducing effect of berberine. In this paper, the physicochemical properties, the lipid-lowering mechanism, and studies of the modification of berberine all are discussed to promote the development of berberine as a lipid-lowering agent. Subsequently, this paper provides some insights into the deficiencies of berberine in the study of lipid-lowering drug, and based on the situation, some proposals are put forward.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
1
2
3
|
|
|
Molecules
3 публикации, 8.11%
|
|
|
Frontiers in Pharmacology
3 публикации, 8.11%
|
|
|
Bioorganic Chemistry
2 публикации, 5.41%
|
|
|
ChemistrySelect
2 публикации, 5.41%
|
|
|
Naunyn-Schmiedeberg's Archives of Pharmacology
2 публикации, 5.41%
|
|
|
Current Topics in Medicinal Chemistry
1 публикация, 2.7%
|
|
|
Arabian Journal of Chemistry
1 публикация, 2.7%
|
|
|
Journal of Pharmaceutical and Biomedical Analysis
1 публикация, 2.7%
|
|
|
Phytomedicine Plus
1 публикация, 2.7%
|
|
|
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
1 публикация, 2.7%
|
|
|
Polymers
1 публикация, 2.7%
|
|
|
Expert Opinion on Therapeutic Patents
1 публикация, 2.7%
|
|
|
Evidence-based Complementary and Alternative Medicine
1 публикация, 2.7%
|
|
|
Expert Reviews in Molecular Medicine
1 публикация, 2.7%
|
|
|
Heterocycles
1 публикация, 2.7%
|
|
|
Current Organic Chemistry
1 публикация, 2.7%
|
|
|
Journal of Materials Chemistry B
1 публикация, 2.7%
|
|
|
Clinical Rheumatology
1 публикация, 2.7%
|
|
|
Mini-Reviews in Medicinal Chemistry
1 публикация, 2.7%
|
|
|
Beilstein Journal of Organic Chemistry
1 публикация, 2.7%
|
|
|
Fitoterapia
1 публикация, 2.7%
|
|
|
Russian Chemical Reviews
1 публикация, 2.7%
|
|
|
Journal of Agricultural and Food Chemistry
1 публикация, 2.7%
|
|
|
Journal of Molecular Liquids
1 публикация, 2.7%
|
|
|
PLoS ONE
1 публикация, 2.7%
|
|
|
Natural Product Communications
1 публикация, 2.7%
|
|
|
Sustainable Chemistry and Pharmacy
1 публикация, 2.7%
|
|
|
NFS Journal
1 публикация, 2.7%
|
|
|
Journal of Advanced Research
1 публикация, 2.7%
|
|
|
Chemical Physics
1 публикация, 2.7%
|
|
|
1
2
3
|
Издатели
|
2
4
6
8
10
12
|
|
|
Elsevier
11 публикаций, 29.73%
|
|
|
MDPI
4 публикации, 10.81%
|
|
|
Bentham Science Publishers Ltd.
3 публикации, 8.11%
|
|
|
Frontiers Media S.A.
3 публикации, 8.11%
|
|
|
Springer Nature
3 публикации, 8.11%
|
|
|
Wiley
2 публикации, 5.41%
|
|
|
King Saud University
1 публикация, 2.7%
|
|
|
Taylor & Francis
1 публикация, 2.7%
|
|
|
Hindawi Limited
1 публикация, 2.7%
|
|
|
Cambridge University Press
1 публикация, 2.7%
|
|
|
The Japan Institute of Heterocyclic Chemistry
1 публикация, 2.7%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 2.7%
|
|
|
Beilstein-Institut
1 публикация, 2.7%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 2.7%
|
|
|
American Chemical Society (ACS)
1 публикация, 2.7%
|
|
|
Public Library of Science (PLoS)
1 публикация, 2.7%
|
|
|
SAGE
1 публикация, 2.7%
|
|
|
2
4
6
8
10
12
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
37
Всего цитирований:
37
Цитирований c 2024:
17
(45.94%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Li D. et al. Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs // Current Topics in Medicinal Chemistry. 2020. Vol. 20. No. 28. pp. 2634-2647.
ГОСТ со всеми авторами (до 50)
Скопировать
Li D., Pan Yu., Xiao W., Wang Z., Zhao L. Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs // Current Topics in Medicinal Chemistry. 2020. Vol. 20. No. 28. pp. 2634-2647.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.2174/1568026620666200908165913
UR - https://doi.org/10.2174/1568026620666200908165913
TI - Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs
T2 - Current Topics in Medicinal Chemistry
AU - Li, Dong-dong
AU - Pan, Yu
AU - Xiao, Wei
AU - Wang, Zhen-Zhong
AU - Zhao, Lin-Guo
PY - 2020
DA - 2020/09/09
PB - Bentham Science Publishers Ltd.
SP - 2634-2647
IS - 28
VL - 20
PMID - 32901585
SN - 1568-0266
SN - 1873-4294
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2020_Li,
author = {Dong-dong Li and Yu Pan and Wei Xiao and Zhen-Zhong Wang and Lin-Guo Zhao},
title = {Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs},
journal = {Current Topics in Medicinal Chemistry},
year = {2020},
volume = {20},
publisher = {Bentham Science Publishers Ltd.},
month = {sep},
url = {https://doi.org/10.2174/1568026620666200908165913},
number = {28},
pages = {2634--2647},
doi = {10.2174/1568026620666200908165913}
}
Цитировать
MLA
Скопировать
Li, Dong-dong, et al. “Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs.” Current Topics in Medicinal Chemistry, vol. 20, no. 28, Sep. 2020, pp. 2634-2647. https://doi.org/10.2174/1568026620666200908165913.